Circulatory shock.
Jean-Louis Vincent, Daniel De Backer
https://pubmed.ncbi.nlm.nih.gov/24171518/Actively Recruiting
Led by Jimma University · Updated on 2025-07-23
226
Participants Needed
1
Research Sites
19 weeks
Total Duration
This research aims to study the heart problems that can occur in adult patients with sepsis and how these heart issues affect the course and outcome of the disease. The study will be conducted at Jimma University Medical Center in Ethiopia from May 2025 to May 2026, focusing on adults aged 18 and older diagnosed with sepsis. Participants will be divided into groups based on whether they have heart involvement, identified through symptoms, blood tests, ECG, and echocardiography. The study will explore how these cardiac issues persist, affect functional ability, and influence survival over one year using statistical methods. The study includes two groups one receiving standard treatment for sepsis without signs of heart problems, and another group treated for sepsis along with additional management for heart failure when indicated. Both groups will be followed for 9 to 12 months, with ongoing assessment of cardiac symptoms and treatment effects. Data collection will use structured forms, and advanced analyses will evaluate survival and predictors of adverse outcomes. Participants will be monitored regularly over one year to observe survival and changes in heart abnormalities. Evaluations will include clinical assessments, biomarker tests such as troponin and BNP, ECG, echocardiography, and quality of life measurements using standardized tools. The main outcome is a combination of survival and persistence or resolution of heart problems at 1, 3, and 6 months after hospital discharge. The study will also assess functional capacity and quality of life at six months. Safety and disease progression will be closely followed throughout the study period.
CONDITIONS
Sepsis and Myocarditis
K
Kedir Negesso Tukeni, MD, Internist, Cardiologist
K
Kidus Tesfaye Bezabih, MD, Internist
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jimma University
Lead Sponsor
Ethiopian Society of Cardiac Professionals
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - 9 to 12 months
Participants are observed to assess cardiac manifestations of sepsis and receive standard treatment for sepsis and, if applicable, additional management for cardiac failure.
Visits at 1, 3, and 6 months post discharge for outcome assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jean-Louis Vincent, Daniel De Backer
https://pubmed.ncbi.nlm.nih.gov/24171518/Jiayu Song, Xiaolei Fang, Kaixuan Zhou...
https://pubmed.ncbi.nlm.nih.gov/37859613/Jacob C Jentzer, Patrick R Lawler, Holly K Van Houten...
https://pubmed.ncbi.nlm.nih.gov/36722388/Reverien Habimana, Insu Choi, Hwa Jin Cho...
https://pubmed.ncbi.nlm.nih.gov/32506871/Alain Rudiger, Mervyn Singer
https://pubmed.ncbi.nlm.nih.gov/17452940/M W Merx, C Weber
https://pubmed.ncbi.nlm.nih.gov/17698745/Hailu Abera Mulatu, Tola Bayisa, Yoseph Worku...
https://pubmed.ncbi.nlm.nih.gov/33680740/Arthur Kwizera, Olivier Urayeneza, Pierre Mujyarugamba...
https://pubmed.ncbi.nlm.nih.gov/34939034/Jimma University
Lead Sponsor
Ethiopian Society of Cardiac Professionals
Collaborating Sponsor